Physician profile
Michael Rosen
NPI 1114910890
$2,181.80
in general payments reported to CMS, 2019-2025
13 companies · $508 in 2025
The $508 reported for 2025 was more than what a typical Internal Medicine provider received nationally (typical 2025 total: $156).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $1,054 · 2022: $250 · 2023: $257 · 2024: $114 · 2025: $508.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $878.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $878.17 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Salix Pharmaceuticals, A Division of Bausch Health US, LLC | $632.57 | 2019-2025 | Xifaxan |
| Medtronic USA, INC. | $205.05 | 2019 | |
| Neurocrine Biosciences, INC. | $175.00 | 2019 | |
| Allergan, INC. | $150.00 | 2019 | |
| Lilly USA, LLC | $131.70 | 2023 | Mounjaro |
| Gilead Sciences, INC. | $125.00 | 2019 | |
| Viiv Healthcare Company | $125.00 | 2023 | Dovato |
| Boehringer Ingelheim Pharmaceuticals, INC. | $125.00 | 2019 | |
| Glaxosmithkline, LLC. | $125.00 | 2022 | |
| Esperion Therapeutics, INC. | $124.97 | 2022 | |
| Novo Nordisk INC | $116.53 | 2019 | |
| Ethicon US, LLC | $113.90 | 2024 | Stratafix, Dermabond |
| Boston Scientific Corporation | $32.08 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Michael Rosen listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.